JOEY News Alert Joey New York Inc (JOEY) 0.2600 02/15/2015 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Joey New York Inc (JOEY) 0.2600 $JOEY

Joey New York Brief Analyst Coverage Initiated: Brief Report by Small Cap Street and BrokerBank Securities, Inc.
PR Newswire - Thu Oct 02, 6:00AM CDT
Joey New York, Inc. (OTCBB: JOEY) - As of June 2014, IBIS World estimates that Cosmetics and Beauty Products Manufacturing in the United States was a $52 billion industry with revenues growing at an annual average rate of 4.9% per year from 2009 to 2014.

Joey New York, Inc. Moving Forward With CAPGreenberg And Intended Acquistion
ACCESSWIRE - Thu Sep 11, 8:02AM CDT
SUNNY ISLES, FL / ACCESSWIRE / September 11, 2014 / Joey New York, Inc. (OTCQB: JOEY) through the efforts of CAPGreenberg, LLC, entered into a letter of intent to acquire a niche beauty and health company. The targeted health and beauty care company, generated sales of more than $10,000,000 during the trailing twelve month period. CAPGreenberg is focused to bring strategic planning and other potential acquisitions to JOEY.

Joey New York Moving Ahead With CAPGreenberg, LLC.
ACCESSWIRE - Wed Sep 03, 8:54AM CDT
SUNNY ISLES, FL / ACCESSWIRE / September 3, 3014 / Earlier this year Joey New York, Inc. (OTCQB: JOEY) retained the services of CAPGreenberg, LLC. to render strategic guidance within the skin care and beauty industry.

Joey New York Looks to Expand Distribution
ACCESSWIRE - Fri Aug 29, 11:16AM CDT
SUNNY ISLES, FL / ACCESSWIRE / August 29, 2014 / Joey New York, Inc. (OTCQB: JOEY) announced today that it continues to fulfill orders for one of it's best selling lines, "Quick Results Coconut Water Collection" to it's current retail partners. "We are very pleased with consumer response to this collection and intend to expand our distribution by adding additional retail outlets," stated Joey Chancis, CEO and Founder of Joey New York.

Joey New York Announces Organizational Plan For Marketing and Distribution
ACCESSWIRE - Fri Aug 22, 7:52AM CDT
SUNNY ISLES, FL / ACCESSWIRE / August 22, 2014 / Joey New York, Inc. (OTCQB: JOEY) announced today its organizational plan for marketing and distribution. This strategy will allow the "JOEY" brand to co-exist in the prestige, masstige, health & well- being and mass market channels. The Prestige brand will be a luxury vitamin infused collection called VitaMinute Skin Technologies which will be powered by The Joey New York Brand. This is a collection that will utilize the more than 20 years of product development of skin care experience of items that deliver quick and effective results with a new high end luxury look keeping up with the ever changing evolution of the prestige beauty industry. The other brands for the remaining distribution channels are still in development. The Company recognizes that Joey New York the original brands namesake is valuable to the global markets. The plan is to develop Joey New York Beauty for a big box retailer exclusively. Joey New York's Coconut Water based skin care products are currently sold in the masstige space plus an aromatherapy skin care collection for the health & well-being markets based on their fast acting quick results mantra currently on the pipeline. Each Category will have complete differentiation in product offerings, technology, designs and marketing message. "The goal is to be able to develop exceptional skin care products with a variety of technologies to offer consumers a choice based on their skin care needs, price range and lifestyle without cannibalizing or being too product intensive in any single marketplace," said Joey Chancis CEO of Joey New York, Inc.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading